Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
ResMed Community
NYSE:RMD Community
1
Narratives
written by author
0
Comments
on narratives written by author
77
Fair Values set
on narratives written by author
Create a narrative
ResMed
Popular
Undervalued
Overvalued
Community Investing Ideas
ResMed
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Calabasas Facility And NightOwl Test Will Elevate Production Efficiency
Key Takeaways Strategic investments and product rollouts are expected to boost market share and revenue growth, highlighting a focus on innovation and increased production capacity. Exemption from U.S. tariffs and a robust pipeline of margin improvement initiatives are aimed at preserving profitability and supporting gross margin expansion.
View narrative
US$263.15
FV
8.5% undervalued
intrinsic discount
7.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
40
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
RMD
RMD
ResMed
Your Fair Value
US$
Current Price
US$240.66
38.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
7b
2015
2018
2021
2024
2025
2027
2030
Revenue US$7.1b
Earnings US$1.9b
Advanced
Set Fair Value